| 英文别名 |
(2α)-Methyl Megestrol Acetate;(2α)-Methyl Megestro;(2β)-Methyl Megestrol Acetate;[(2R,8R,9S,10R,13S,14S,17R)-17-acetyl-2,6,10,13-tetramethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate;(2alpha)-17-(Acetyloxy)-2,6-dimethylpregna-4,6-diene-3,20-dione;(2 alpha )-Methyl Megestrol Acetate;Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-2,6-dimethyl-, (2alpha)-;MEGESTROL ACETATE IMPURITY H [EP IMPURITY];Q27271363;2.ALPHA.,6-DIMETHYL-3,20-DIOXOPREGNA-4,6-DIEN-17-YL ACETATE, (+)-;(2beta)-Methyl Megestrol Acetate;(2?)-Methyl Megestrol Acetate;Megestrol acetate specified impurity H;DTXCID60160735;2alpha,6-Dimethyl-3,20-dioxopregna-4,6-dien-17-yl acetate;(2alpha)-Methyl megestrol acetate;2.ALPHA.,6-DIMETHYL-3,20-DIOXOPREGNA-4,6-DIEN-17-YL ACETATE;911S0BD9BB;DTXSID40238244;UNII-911S0BD9BB;PREGNA-4,6-DIENE-3,20-DIONE, 17-(ACETYLOXY)-2,6-DIMETHYL-, (2.ALPHA.)-;907193-65-1;Pregna-4,6-diene-3,20-dione, 17-(acetyloxy)-2,6-dimethyl-, (2a)- (9CI); 2a,6-Dimethyl-3,20-dioxopregna-4,6-dien-17-yl acetate;2alpha,6-Dimethyl-3,20-dioxopregna-4,6-dien-17-yl acetate, (+)-;MEGESTROL ACETATE IMPURITY H (EP IMPURITY);Megestrol acetate specified impurity H [EP] |
